LEBEL FRANCOIS (Chief Medical Officer) sold 1.0% of their position (2.57K shares) of SPECTRUM PHARMACEUTICALS INC on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/5/2022ACC: 0001209191-22-023224
Officer· Chief Medical Officer
Since Jun 2019
-2.57K
Net shares
Net seller
$3.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.57K disposed
Non-Derivative Transactions2
Common Stock, $0.001 par value
Direct
Shares
−1.21K
Price / share
$1.35
Trade value
$1.63K
% of position
0.5%
4/4/2022
255.09K→253.88K
Common Stock, $0.001 par value
Direct
Shares
−1.37K
Price / share
$1.41
Trade value
$1.93K
% of position
0.5%
4/5/2022
253.88K→252.51K
Total
Net shares
−2.57K
Net value
-$3.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 4/4/2022 | S · Sale | −1.21K | $1.35 | $1.63K | 0.5% | 255.09K | 253.88K |
| Common Stock, $0.001 par value Direct | 4/5/2022 | S · Sale | −1.37K | $1.41 | $1.93K | 0.5% | 253.88K | 252.51K |
| Total | −2.57K | -$3.55K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.001 par value
IndirectShares owned7.23K
Total
7.23K indirect7.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 7.23K | Indirect |
| Total | 7.23K | 7.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported